The No Surprises Act, included within the Consolidated Appropriations Act, a massive piece of COVID-19 relief legislation signed into law in late 2020, is set to become effective January 1, 2022. While the laudable goal of the Act is to protect patients from surprise billing, the law and its associated rules will also impose significant compliance burdens on health plans, providers, and facilities with regard to their patient billing and claims submission processes, as well as with respect to making novel patient and plan billing rights disclosures and meeting the Act’s unprecedented price transparency requirements. The requirements of the No Surprises Act are complicated by their complex interaction with an inconsistent and confusing patchwork of state laws and administrative rules on the same subject.

With the January 1, 2022, implementation deadline approaching rapidly, health plans, health care facilities, providers, and ancillary service entities that support hospital in-patient, out-patient, and emergency operations are scrambling to figure out what the new federal law and its implementing rules means for them.

In this session, Epstein Becker Green’s Helaine Fingold and Bob Hearn help to make sense of the Act, examine the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces, and discuss specific and “operationalized” guidance to providers, facilities, and health plans on complying with the Act, including its challenging interaction with state balance billing laws. Their insights are based on experience in this arena and are rededicated to deciphering the complex interaction between state law and the new federal law. Click here for more information or to register for this HealthcareWebSummit event.